BML-EI369-0025 Enzo Life Sciences BML 275, 25 mg, AMPK inhibitor

Description

The BML-EI369-0025 is a cell-permeable pyrrazolopyrimidine derivative identified as an AMPK inhibitor. It functions by ATP-competitively inhibiting AMP-activated protein kinase, with a reported Ki of 109 nM in the absence of AMP. This compound is supplied by Enzo Life Sciences, a subsidiary of Enzo Biochem, Inc., headquartered in New York. It is designed for laboratory research applications.

• AMPK inhibitor
• Cell-permeable pyrrazolopyrimidine derivative
• ATP-competitively inhibits AMP-activated protein kinase
• Ki = 109 nM (in the absence of AMP)

Shop today for the BML-EI369-0025 to meet your research requirements!